Search Results

Filter
  • 1-10 of  439,144 results for ""Post Hoc Analysis""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Factors driving change in WOMAC pain score: a post hoc analysis of a phase 2b trial of lorecivivint, a potential disease-modifying intra-articular treatment for knee osteoarthritis

  • Source: Osteoarthritis and cartilage 2020 28, S363 (S363-S364) Published by: W.B. Saunders Ltd NetherlandsThis document should be cited as: . Factors driving change in WOMAC pain score: a post hoc analysis of a

Record details

×

High-quality colon cleansing and multiple neoplasia detection with 1L NER1006 versus mid-volume options: post hoc analysis of phase 3 clinical trials

  • Source: Endoscopy international open 2020 8 5, E628 (E628-E635) Published by: Georg Thieme Verlag GermanyThis document should be cited as: . High-quality colon cleansing and multiple neoplasia detection with 1L NER1006 versus mid-volume options: post

Record details

×

Heterogeneity of treatment effect of prophylactic pantoprazole in adult ICU patients: a post hoc analysis of the SUP-ICU trial

  • Source: Intensive care medicine 2020 46 4, 717 (717-726) Published by: Springer GermanyThis document should be cited as: . Heterogeneity of treatment effect of prophylactic pantoprazole in adult ICU patients: a post hoc

Record details

×

Treatment with lorecivivint, a novel, intra-articular CLK/DYRK1A inhibitor that modulates the WNT pathway, led to improved responder outcomes in subjects with knee osteoarthritis: a post HOC analysis of a phase 2b trial

  • Source: Osteoarthritis and cartilage 2020 28, S358 (S358-) Published by: W.B. Saunders Ltd NetherlandsThis document should be cited as: . Treatment with lorecivivint, a novel, intra-articular CLK/DYRK1A inhibitor that modulates the WNT pathway, led to improved responder outcomes in subjects with knee

Record details

×

DULAGLUTIDE REDUCES HBA1C IRRESPECTIVE OF ANTIHYPERGLYCEMIC AGENTS, DURATION OF DIABETES, BMI AND WEIGHT LOSS: a POST HOC ANALYSIS FROM THE REWIND TRIAL

  • Source: Journal of the American College of Cardiology 2020 75 11, 1951 (1951-) Published by: Elsevier USA NetherlandsThis document should be cited as: . DULAGLUTIDE REDUCES HBA1C IRRESPECTIVE OF ANTIHYPERGLYCEMIC AGENTS, DURATION OF DIABETES, BMI AND WEIGHT LOSS: a POST

Record details

×

Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: a Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR)

  • Source: Journal of clinical oncology 2020 38 15, 1702 (1702-1710) Published by: NLM (Medline) United StatesThis document should be cited as: . Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: a Post

Record details

×

Relationship between pain reduction and improvement in health-related quality of life in patients with knee pain due to osteoarthritis receiving duloxetine: exploratory post hoc analysis of a Japanese phase 3 randomized study

  • Source: Journal of pain research 2020 13, 181 (181-191) Published by: Dove Medical Press Ltd. New ZealandThis document should be cited as: . Relationship between pain reduction and improvement in health-related quality of life in patients with knee pain due to osteoarthritis receiving duloxetine:

Record details

×

The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysis

  • Source: Diabetes, obesity & metabolism 2020 22 4, 549 (549-556) Published by: Blackwell Publishing Ltd United KingdomThis document should be cited as: . The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a

Record details

×

139 Early Response with Valbenazine and Long-Term Symptom Reduction in Patients with Tardive Dyskinesia: post Hoc Analysis of the KINECT 3 Study

  • Source: CNS spectrums 2020 25 2, 288 (288-289) Published by: NLM (Medline) United StatesThis document should be cited as: . 139 Early Response with Valbenazine and Long-Term Symptom Reduction in Patients with Tardive Dyskinesia: post

Record details

×

Early response with valbenazine and long-term symptom reduction in patients with tardive dyskinesia: post hoc analysis of the KINECT 3 study

  • Source: CNS spectrums 2020 25 2, 288 (288-289) Published by: Cambridge University Press NetherlandsThis document should be cited as: . Early response with valbenazine and long-term symptom reduction in patients with tardive dyskinesia: post

Record details

×
  • 1-10 of  439,144 results for ""Post Hoc Analysis""